WHO. Cancer https://www.who.int/news-room/fact-sheets/detail/cancer (2022).

McPhail, S., Johnson, S., Greenberg, D., Peake, M. & Rous, B. Stage at diagnosis and early mortality from cancer in England. Br. J. Cancer 112, S108–S115 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Dolly, S. O. et al. The effectiveness of the Guy’s rapid diagnostic clinic (RDC) in detecting cancer and serious conditions in vague symptom patients. Br. J. Cancer 124, 1079–1087 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Sewell, B. et al. Rapid cancer diagnosis for patients with vague symptoms: a cost-effectiveness study. Br. J. Gen. Pract. 70, e186–e192 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Patt, D. et al. Impact of COVID-19 on cancer care: how the pandemic is delaying cancer diagnosis and treatment for American seniors. JCO Clin. Cancer Inform. 4, 1059–1071 (2020).

Article  PubMed  Google Scholar 

McCormack, V. & Aggarwal, A. Early cancer diagnosis: reaching targets across whole populations amidst setbacks. Br. J. Cancer 124, 1181–1182 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Frangioni, J. V. New technologies for human cancer imaging. J. Clin. Oncol. 26, 4012–4021 (2008).

Article  PubMed  PubMed Central  Google Scholar 

Romero, D. Tracking Cancer in Liquid Biopsies https://media.nature.com/original/magazine-assets/d42859-020-00070-z/d42859-020-00070-z.pdf (2020).

Tellez-Gabriel, M., Knutsen, E. & Perander, M. Current status of circulating tumor cells, circulating tumor DNA, and exosomes in breast cancer liquid biopsies. Int. J. Mol. Sci. https://doi.org/10.3390/ijms21249457 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Eslami, S. Z., Cortes-Hernandez, L. E., Thomas, F., Pantel, K. & Alix-Panabieres, C. Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade. Br. J. Cancer https://doi.org/10.1038/s41416-022-01819-1 (2022).

Article  Google Scholar 

Suhail, Y. et al. Systems biology of cancer metastasis. Cell Syst. 9, 109–127 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Braun, S. et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N. Engl. J. Med. 353, 793–802 (2005).

Article  CAS  PubMed  Google Scholar 

Recasens, A. & Munoz, L. Targeting cancer cell dormancy. Trends Pharmacol. Sci. 40, 128–141 (2019).

Article  CAS  PubMed  Google Scholar 

Werner, S., Heidrich, I. & Pantel, K. Clinical management and biology of tumor dormancy in breast cancer. Semin. Cancer Biol. 78, 49–62 (2022).

Article  CAS  PubMed  Google Scholar 

Goldkorn, A. et al. Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer. J. Clin. Oncol. 32, 1136–1142 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Riethdorf, S. et al. Prognostic impact of circulating tumor cells for breast cancer patients treated in the neoadjuvant “Geparquattro” trial. Clin. Cancer Res. 23, 5384–5393 (2017).

Article  CAS  PubMed  Google Scholar 

Bidard, F. C. et al. Circulating tumor cells in breast cancer patients treated by neoadjuvant chemotherapy: a meta-analysis. J. Natl Cancer Inst. 110, 560–567 (2018).

Article  PubMed  Google Scholar 

Aggarwal, C. et al. Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer. Ann. Oncol. 24, 420–428 (2013).

Article  CAS  PubMed  Google Scholar 

Abdalla, T. S. A. et al. Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancer. PLoS ONE 16, e0252897 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rink, M. et al. Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study. Eur. Urol. 61, 810–817 (2012).

Article  CAS  PubMed  Google Scholar 

Gazzaniga, P. et al. Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer. Int. J. Cancer 135, 1978–1982 (2014).

Article  CAS  PubMed  Google Scholar 

Grobe, A. et al. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity. Clin. Cancer Res. 20, 425–433 (2014).

Article  PubMed  Google Scholar 

Garrel, R. et al. Circulating tumor cells as a prognostic factor in recurrent or metastatic head and neck squamous cell carcinoma: the CIRCUTEC prospective study. Clin. Chem. 65, 1267–1275 (2019).

Article  CAS  PubMed  Google Scholar 

Effenberger, K. E. et al. Improved risk stratification by circulating tumor cell counts in pancreatic cancer. Clin. Cancer Res. 24, 2844–2850 (2018).

Article  CAS  PubMed  Google Scholar 

Srivastava, S. et al. Cancer overdiagnosis: a biological challenge and clinical dilemma. Nat. Rev. Cancer 19, 349–358 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heidrich, I., Deitert, B., Werner, S. & Pantel, K. Liquid biopsy for monitoring of tumor dormancy and early detection of disease recurrence in solid tumors. Cancer Metastasis Rev. https://doi.org/10.1007/s10555-022-10075-x (2023).

Article  PubMed  PubMed Central  Google Scholar 

Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 (2000).

Article  CAS  PubMed  Google Scholar 

Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).

Article  CAS  PubMed  Google Scholar 

Fidler, I. J. Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2′-deoxyuridine. J. Natl Cancer Inst. 45, 773–782 (1970).

CAS  PubMed  Google Scholar 

Montanari, M. et al. Epithelial-mesenchymal transition in prostate cancer: an overview. Oncotarget 8, 35376–35389 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Yeung, K. T. & Yang, J. Epithelial-mesenchymal transition in tumor metastasis. Mol. Oncol. 11, 28–39 (2017).

Article  PubMed  Google Scholar 

Liu, T. et al. Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer. J. Surg. Oncol. 107, 188–194 (2013).

Article  CAS  PubMed  Google Scholar 

Tsang, J. Y. et al. P-cadherin and vimentin are useful basal markers in breast cancers. Hum. Pathol. 44, 2782–2791 (2013).

Article  CAS  PubMed  Google Scholar 

Nitta, T. et al. Prognostic significance of epithelial-mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray. Br. J. Cancer 111, 1363–1372 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Satelli, A. & Li, S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol. Life Sci. 68, 3033–3046 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang, J. & Weinberg, R. A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 14, 818–829 (2008).

Article  CAS  PubMed  Google Scholar 

Zeeshan, R. & Mutahir, Z. Cancer metastasis — tricks of the trade. Bosn. J. Basic Med. Sci. 17, 172–182 (2017).

CAS  PubMed  PubMed Central  Google Scholar 

Donato, C. et al. Hypoxia triggers the intravasation of clustered circulating tumor cells. Cell Rep. 32, 108105 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eslami, S. Z., Cortes-Hernandez, L. E. & Alix-Panabieres, C. The metastatic cascade as the basis for liquid biopsy development. Front. Oncol. 10, 1055 (2020).

Article  Google Scholar 

Follain, G. et al. Hemodynamic forces tune the arrest, adhesion, and extravasation of circulating tumor cells. Dev. Cell 45, 33–52.e12 (2018).